Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 315 (1980), S. 177-179 
    ISSN: 1432-1912
    Keywords: Lisuride ; Reserpine-induced rigidity ; Spinal cord ; Subarachnoid space
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Muscular rigidity was induced by reserpine (10 mg/kg) in rats and the tonic activity of the gastrocnemius muscle was recorded in the electromyogram. Systemic administration of lisuride, an ergoline, resulted in a dose-dependent depression of rigidity. To examine the spinal cord as a site of action for lisuride to depress reserpine-induced rigidity, a method for the chronic catheterization of the lumbar spinal subarachnoid space was used, which allowed the administration of drugs to reserpinized, intact rats without anaesthesia. Lisuride injected into the lumbar spinal subarachnoid space resulted in a longlasting depression of rigidity. These results suggest that the spinal cord is an important site of action of lisuride.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 300 (1977), S. 195-198 
    ISSN: 1432-1912
    Keywords: 6-Aminonicotinamide ; Reserpine ; L-DOPA ; Lisuride ; Muscular rigidity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Persistent and transient muscular rigidities were induced by 6-aminonicotinamide (6-AN) and reserpine, respectively, in rats and recorded electromyographically. Very low doses of lisuride (25 or 50 μg/kg) reduced or abolished the increased electromyographic activity in the gastrocnemius muscle. Similar results were obtained with the combination of L-DOPA (100 mg/kg) plus benserazide (25 mg/kg). Methysergide was inactive. It is suggested that lisuride could be of value in the therapy of Parkinson's disease.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...